Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2009

01.05.2009 | Original Article

The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population

verfasst von: Li Yang, Huaijun Zhu, Bo Zhou, Haijuan Gu, Hongli Yan, Naping Tang, Hanzhang Dong, Qingmin Sun, Rihong Cong, Guoyu Chen, Bin Wang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction The C-31G polymorphism in the survivin promoter could de-represse the cell-cycle-dependent transcription of the human survivin gene, resulting in overexpression of survivin. This survivin mutation has only been studied on cervical carcinoma. However, no study has ever been conducted to evaluate the effect of the polymorphism on other cancers, including gastric cancer. Methods In this hospital-based, case–control study, we investigated the association between the survivin C-31G polymorphism and risk of gastric cancer in a Chinese population using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) protocols. Results No statistically significant association was observed between gastric cancer risk and the variant genotype (GG + GC). However, the variant genotype (GG + GC) was either associated with risk of distal gastric cancer (odds ratios = 0.50, 95% confidence interval = 0.30–0.83) or with risk of well-differentiated tumor (odds ratios = 0.46, 95% confidence interval = 0.22–0.97). Conclusion Our results demonstrate that the survivin C-31G polymorphism may be involved in distal gastric carcinogenesis and tumor differentiation in a Chinese population.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130.PubMedCrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130.PubMedCrossRef
4.
Zurück zum Zitat Wu MS, Chen CJ, Lin JT. Host–environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878–1882. doi:10.1158/1055-9965.EPI-04-0792.PubMedCrossRef Wu MS, Chen CJ, Lin JT. Host–environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878–1882. doi:10.​1158/​1055-9965.​EPI-04-0792.PubMedCrossRef
13.
Zurück zum Zitat Ikeguchi M, Kaibara N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med. 2001;8:661–666.PubMed Ikeguchi M, Kaibara N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med. 2001;8:661–666.PubMed
17.
Zurück zum Zitat Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808–1812.PubMed Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808–1812.PubMed
18.
Zurück zum Zitat Zhu XD, Lin GJ, Qian LP, Chen ZQ. Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats. World J Gastroenterol. 2003;9:1435–1438.PubMed Zhu XD, Lin GJ, Qian LP, Chen ZQ. Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats. World J Gastroenterol. 2003;9:1435–1438.PubMed
20.
Zurück zum Zitat Wang ZN, Xu HM, Jiang L, Zhou X, Lu C, Zhang X. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol. 2004;10:3094–3098.PubMed Wang ZN, Xu HM, Jiang L, Zhou X, Lu C, Zhang X. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol. 2004;10:3094–3098.PubMed
22.
Zurück zum Zitat Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta. 2000;1493:188–194.PubMed Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta. 2000;1493:188–194.PubMed
23.
Zurück zum Zitat Li F, Altieri DC. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 1999;59:3143–3151.PubMed Li F, Altieri DC. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 1999;59:3143–3151.PubMed
24.
Zurück zum Zitat Xu Y, Fang F, Ludewig G, Jones G, Jones D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004;23:419–429. doi:10.1089/1044549041474788.PubMedCrossRef Xu Y, Fang F, Ludewig G, Jones G, Jones D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004;23:419–429. doi:10.​1089/​1044549041474788​.PubMedCrossRef
29.
Zurück zum Zitat Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 2003;63:7724–7732.PubMed Tu SP, Jiang XH, Lin MC, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 2003;63:7724–7732.PubMed
32.
Zurück zum Zitat Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-kappaB, survivin, Bcl–2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10:22–25.PubMed Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-kappaB, survivin, Bcl–2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10:22–25.PubMed
35.
Zurück zum Zitat Wakana Y, Kasuya K, Katayanagi S, et al. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep. 2002;9:1213–1218.PubMed Wakana Y, Kasuya K, Katayanagi S, et al. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep. 2002;9:1213–1218.PubMed
Metadaten
Titel
The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population
verfasst von
Li Yang
Huaijun Zhu
Bo Zhou
Haijuan Gu
Hongli Yan
Naping Tang
Hanzhang Dong
Qingmin Sun
Rihong Cong
Guoyu Chen
Bin Wang
Publikationsdatum
01.05.2009
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2009
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0441-5

Weitere Artikel der Ausgabe 5/2009

Digestive Diseases and Sciences 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.